Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer
NCT00553566 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1600
Last updated 2014-01-10
Summary
RATIONALE: Learning about the long-term effects of dietary, lifestyle, and environmental factors on the risk of cancer progression and recurrence may help the study of bladder cancer in the future.
PURPOSE: This clinical trial is studying how dietary, lifestyle, and environmental factors affect patients with early-stage bladder cancer.
Conditions
Interventions
- PROCEDURE
-
medical chart review
- PROCEDURE
-
questionnaire administration
- PROCEDURE
-
study of socioeconomic and demographic variables
Sponsors & Collaborators
-
University of Birmingham
lead OTHER
Principal Investigators
-
Maurice Zeegers · University of Birmingham
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer
NCT01958372 ·Status: COMPLETED ·Phase: PHASE1
-
High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer
NCT00003623 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of AL8326 in Healthy Subjects
NCT07132957 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Effect of Food on Oral LBH589 Absorption in Patients With Advanced Solid Tumors
NCT00570284 ·Status: COMPLETED ·Phase: PHASE1
-
Selenium in the Prevention of Cancer
NCT00022165 ·Status: COMPLETED ·Phase: NA
-
Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy
NCT00379665 ·Status: COMPLETED ·Phase: PHASE2
-
Collaborative Network to Take Responsibility for Oral Anticancer Therapy
NCT02861209 ·Status: UNKNOWN ·Phase: NA
-
Relationship of Nutritional Status to Chemotherapy Treatment Completion and Outcomes in Cancer Patients
NCT07059598 ·Status: COMPLETED
-
Docetaxel in Treating Patients With Solid Tumors
NCT00003565 ·Status: COMPLETED ·Phase: PHASE2
-
Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer
NCT00905658 ·Status: UNKNOWN ·Phase: PHASE2
-
S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo
NCT00775645 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Pharmacokinetic Study of TAK-285 in Patients With Advanced Cancer
NCT00535522 ·Status: COMPLETED ·Phase: PHASE1
-
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
NCT03987555 ·Status: SUSPENDED
-
Pharmacokinetics and Metabolism Study in Healthy Male Participants
NCT03247283 ·Status: COMPLETED ·Phase: PHASE1
-
Software Monitoring of Treatment Related Toxicities in Advanced Renal Cell Carcinoma
NCT03229083 ·Status: COMPLETED ·Phase: NA
-
Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)
NCT00751205 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-finding Study of BP-C1 in Patients With Stage IV Breast Cancer
NCT04298333 ·Status: COMPLETED ·Phase: PHASE1
-
Benzoylphenylurea in Treating Patients With Advanced Cancer
NCT00010205 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of Carbon-14-Labelled [14C] LY3556050 in Healthy Male Participants
NCT06052462 ·Status: COMPLETED ·Phase: PHASE1
-
Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment
NCT00210249 ·Status: COMPLETED
-
Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia
NCT00003005 ·Status: COMPLETED ·Phase: PHASE1
-
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
NCT01497925 ·Status: COMPLETED ·Phase: PHASE1
-
Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
NCT00088946 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors
NCT02792465 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Nutritional Supplement to Support People With Non-small Cell Lung Cancer
NCT04175769 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA